Search Results - "Fonseca, Cleverson Alves"
-
1
Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC)
Published in PloS one (29-01-2020)“…Sickle cell disease (SCD) consists of a group of hemoglobinopathies in which individuals present highly variable clinical manifestations. Sickle cell anemia…”
Get full text
Journal Article -
2
Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers
Published in PloS one (04-02-2021)“…Priapism is a urologic emergency characterized by an uncontrolled, persistent and painful erection in the absence of sexual stimulation, which can lead to…”
Get full text
Journal Article -
3
Investigation of Lipid Profile and Clinical Manifestations in SCA Children
Published in Disease markers (2020)“…Introduction. Clinical complications in sickle cell anemia (SCA) are heterogeneous and involve several molecules. It has been suggested that SCA individuals…”
Get full text
Journal Article -
4
Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response
Published in Frontiers in pharmacology (09-09-2020)“…Differences in hydroxyurea response in sickle cell anemia may arise due to a series of factors with genetic factors appearing to be predominant. This study…”
Get full text
Journal Article -
5
TGFBR3 Polymorphisms (rs1805110 and rs7526590) Are Associated with Laboratory Biomarkers and Clinical Manifestations in Sickle Cell Anemia
Published in Disease markers (2020)“…Individuals with sickle cell anemia (SCA) present chronic anemia, hemolysis, an exacerbated inflammatory response, and heterogeneous clinical complications,…”
Get full text
Journal Article -
6
Effect of N(Epsilon)-(carboxymethyl)lysine on Laboratory Parameters and Its Association with βS Haplotype in Children with Sickle Cell Anemia
Published in Disease markers (2019)“…The present study aimed to investigate the association of Nε-carboxymethyllysine (CML) with laboratory parameters and βS haplotypes in pediatric sickle cell…”
Get full text
Journal Article -
7
Genetic Polymorphisms Associated with Environmental Exposure to Polycyclic Derivatives in African Children
Published in Disease markers (01-01-2018)“…Background. The nonracial leukopenia may be a result of exposure to polycyclic derivatives (benzene-toluene-xylene (BTX)) and may arise from a possible change…”
Get full text
Journal Article -
8
Progression Free Survival (PFS) Analysis of Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients
Published in Blood (23-11-2021)“…Background: Newly drugs access for MM treatment still a challenge in some countries. One of the most available inductions for TE NDMM patients (pts) worldwide…”
Get full text
Journal Article -
9
Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients
Published in Blood (05-11-2020)“…Background: The inclusion of the CD38-targeting antibody daratumumab (Dara) increases the depth and duration of the response, as demonstrated by Dara-VTd and…”
Get full text
Journal Article -
10
-
11
Effect of Nlysine on Laboratory Parameters and Its Association with [[beta].sup.S] Haplotype in Children with Sickle Cell Anemia
Published in Disease markers (30-09-2019)Get full text
Journal Article